5.1 The Secretary of State and the Welsh Assembly Minister for Health and Social Services have issued directions to the NHS on implementing NICE technology appraisal guidance. When a NICE technology appraisal recommends use of a drug or treatment, or other technology, the NHS must usually provide funding and resources for it within 3 months of the guidance being published. If the Department of Health issues a variation to the 3-month funding direction, details will be available on the NICE website. When there is no NICE technology appraisal guidance on a drug, treatment or other technology, decisions on funding should be made locally.
5.2 When NICE recommends a treatment 'as an option', the NHS must make sure it is available within the period set out in the paragraph above. This means that, if the doctor responsible for the care of a patient thinks that clopidogrel and modified-release dipyridamole is the right treatment for the prevention of occlusive vascular events, it should be available for use, in line with NICE's recommendations.
5.3 NICE has developed tools to help organisations put this guidance into practice (listed below).
Costing report and costing template to estimate the savings and costs associated with implementation.
Audit support for monitoring local practice.